NCT03174756

Brief Summary

Hypochlorous acid (HOCl) in a non-antibiotic antimicrobial agent used in clinical medicine. Nevertheless, its antiplaque oral effect has not been evaluated. Chlorhexidine (CHX) is the gold standard as an antiplaque agent for its high substantivity in plaque and saliva. There are no published studies evaluating the substantivity of hypochlorous acid compared to CHX. Objective: To evaluate the efficacy of mouthwashes of HOCl in substantivity evaluated by reduction of bacterial viability in saliva during 7 hours compared to CHX rinses and a placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2016

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 2, 2017

Completed
Last Updated

October 26, 2017

Status Verified

October 1, 2017

Enrollment Period

1.8 years

First QC Date

May 31, 2017

Last Update Submit

October 24, 2017

Conditions

Keywords

Hypochlorous AcidChlorhexidineAntiplaque agentsSubstantivity

Outcome Measures

Primary Outcomes (1)

  • Substantivity

    Viability reduction (VR) was calculated for each saliva sample by the difference in the percentage of viable bacteria between two times.

    Baseline, 30 Seconds, 1, 3, 5 and 7 hours

Secondary Outcomes (1)

  • Plaque Index

    Baseline and 7 hours

Other Outcomes (1)

  • Adverse effect

    24 hours

Study Arms (5)

HOCl 0.025%

EXPERIMENTAL

15 ml of Hypochlorous acid mouthwash at 0.025%

Drug: Hypochlorous Acid

HOCl 0.05%

EXPERIMENTAL

15 ml of Hypochlorous acid mouthwash at 0.05%

Drug: Hypochlorous Acid

CHX 0.2%

ACTIVE COMPARATOR

15 ml of chlorhexidine mouthwash at 0.2%

Drug: Chlorhexidine

CHX 0.025%

ACTIVE COMPARATOR

15 ml of chlorhexidine at mouthwash0.025%

Drug: Chlorhexidine

Placebo

PLACEBO COMPARATOR

15 ml of Sterile water

Other: Placebo

Interventions

Mouthwashes of antiplaque agents

Also known as: HClO, Hypochlorous Acids
HOCl 0.025%HOCl 0.05%

A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.

Also known as: CHX
CHX 0.025%CHX 0.2%
PlaceboOTHER

Sterile water as placebo

Also known as: Placebos
Placebo

Eligibility Criteria

Age18 Years - 25 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Dentate young men with minimum 22 teeth were considered eligible for the study. Participants should have good dental and gingival status (DMFT index ≤ 3, median of Lobene gingival index ≤ 1) and detectable levels of dental plaque at 7 hours of brushing during the selection process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gloria Ines Lafaurie

Bogotá, 1101, Colombia

Location

Related Publications (5)

  • Lafaurie GI, Calderón JL, Zaror C, Millán LV, Castillo DM. Hypochlorous Acid: A New Alternative as Antimicrobial Agent and For Cell Proliferation for Use in Dentistry. International journal of odontostomatology. 9: 475-481. 2015

    RESULT
  • Castillo DM, Castillo Y, Delgadillo NA, Neuta Y, Jola J, Calderon JL, Lafaurie GI. Viability and Effects on Bacterial Proteins by Oral Rinses with Hypochlorous Acid as Active Ingredient. Braz Dent J. 2015 Oct;26(5):519-24. doi: 10.1590/0103-6440201300388.

  • Chen CJ, Chen CC, Ding SJ. Effectiveness of Hypochlorous Acid to Reduce the Biofilms on Titanium Alloy Surfaces in Vitro. Int J Mol Sci. 2016 Jul 19;17(7):1161. doi: 10.3390/ijms17071161.

  • Moran J, Addy M, Wade W, Milson S, McAndrew R, Newcombe RG. The effect of oxidising mouthrinses compared with chlorhexidine on salivary bacterial counts and plaque regrowth. J Clin Periodontol. 1995 Oct;22(10):750-5. doi: 10.1111/j.1600-051x.1995.tb00257.x.

  • Wang L, Bassiri M, Najafi R, Najafi K, Yang J, Khosrovi B, Hwong W, Barati E, Belisle B, Celeri C, Robson MC. Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity. J Burns Wounds. 2007 Apr 11;6:e5.

MeSH Terms

Interventions

Hypochlorous AcidChlorhexidine

Intervention Hierarchy (Ancestors)

Acids, NoncarboxylicAcidsInorganic ChemicalsChlorine CompoundsReactive Oxygen SpeciesFree RadicalsOxidesOxygen CompoundsBiguanidesGuanidinesAmidinesOrganic Chemicals

Study Officials

  • Gloria Ines Lafaurie, MS

    El Bosque University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The treatment codes of the study were not accessible to the investigators and to the examiner until the data were analyzed
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A double-blind randomized controlled trial with 75 participants was conducted. Participants were assigned using block randomization in five groups: HOCl 0.025% and 0.05%, CHX 0.12% and 0.2% and sterile water as placebo. Participants were instructed to use each rinse solution for 30 seconds after dental prophylaxis. Samples of saliva were taken at baseline and after 30 seconds, 1, 3.5 and 7 hours to assess substantivity establishing the bacterial viability by the fluorescence method.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Magister Clinical Epidemiology

Study Record Dates

First Submitted

May 31, 2017

First Posted

June 2, 2017

Study Start

January 15, 2015

Primary Completion

November 15, 2016

Study Completion

November 30, 2016

Last Updated

October 26, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

No requerid

Locations